Skip to content

A Study on Registration of Carotid Stenosis

A Study on Registration of Carotid Stenosis

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2300073821
Enrollment
Unknown
Registered
2023-07-21
Start date
2023-08-01
Completion date
Unknown
Last updated
2023-07-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Carotid Stenosis

Interventions

Natural queue without prior grouping:None

Sponsors

Dongzhimen Hospital of Beijing University of Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 100 Years

Inclusion criteria

Inclusion criteria: 1) Clinical diagnosis of carotid artery stenosis; 2) Between the ages of 18 and 100, regardless of gender; 3) Informed consent of the patient and signing of the informed consent form.

Exclusion criteria

Exclusion criteria: 1) Patients with acute cardio cerebral Vascular disease were excluded; 2) Exclude patients with severe arrhythmia, atrial fibrillation, and heart failure; 3) Patients with serious primary diseases such as liver, kidney, hematopoietic system, Endocrine system and respiratory system were excluded; 4) Exclude patients who are currently suffering from life-threatening or other serious illnesses; 5) Excluding mental illnesses that researchers believe may limit clinical observation or patient follow-up; 6) Pregnant or lactating women, women with recent pregnancy plans.

Design outcomes

Primary

MeasureTime frame
Stenosis rate of lumen;

Secondary

MeasureTime frame
weight;blood pressure;Bilateral common carotid artery and internal and external carotid artery imaging (maximum plaque location, length, thickness, cross-sectional thickness, residual lumen, original lumen, echogenicity, ulcer length, ulcer width, ulcer depth, and intima media thickness);Test indicators (low density lipoprotein cholesterol, High-density lipoprotein cholesterol, total cholesterol, triglyceride, Glycated hemoglobin, blood sugar, high-sensitivity C-reactive protein, interleukin-6, homocysteine, creatinine, urea, uric acid, Alanine transaminase, cereal grass Transaminase, total bilirubin, Alkaline phosphatase, Lactate dehydrogenase, glutamyltransferase);Symptoms and Treatment of Traditional Chinese Medicine;Surgical/Interventional Treatment Status;Usage of Western Medicines;patient outcomes;

Countries

China

Contacts

Public ContactWu Shengxian

Dongzhimen Hospital of Beijing University of Chinese Medicine

wushx@sina.com+86 135 0138 2919

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026